Novel ¿-conotoxins from C. catus reverse signs of mouse inflammatory pain after systemic administration
Conclusions:
The present study indicates a potential for CVID and CVIE to be developed as systemically active analgesics with no accompanying neurological side-effects.
Source: Molecular Pain - Category: Molecular Biology Authors: Mahsa SadeghiSwetha MuraliRichard LewisPaul AlewoodSarasa MohammadiMacDonald Christie Source Type: research
More News: Brain | Calcium | Chronic Pain | Ganglions | Molecular Biology | Neurology | Pain | Study